/

Other

/

Sarepta Therapeutics

Sarepta Therapeutics

Sarepta Therapeutics

Verified Nov 2026

Other

·

United States flag

Cambridge, Massachusetts

·

Since 1980

Sarepta Therapeutics is a biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts, with 500 to 1,000 employees and estimated revenue of $1 billion to $5 billion. It develops precision genetic medicines for rare genetic diseases, particularly Duchenne muscular dystrophy, and operates facilities in Massachusetts and North Dakota. The company has four FDA-approved DMD therapies, including Elevidys, the first approved gene therapy for the disorder, and maintains a pipeline targeting neuromuscular diseases.

Sarepta Therapeutics

Verified Nov 2026

AT A GLANCE

Founded

1980

Headquarters

United States flag

Cambridge, Massachusetts

Employees

500-1,000

Ownership

Sarepta Therapeutics at a glance

Revenue

$1-5B

Est. band

Employees

500-1,000

Founded

1980

Headquarters

Cambridge, Massachusetts

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Overview

Sarepta Therapeutics is a biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts, with 500 to 1,000 employees and estimated revenue of $1 billion to $5 billion. It develops precision genetic medicines for rare genetic diseases, particularly Duchenne muscular dystrophy, and operates facilities in Massachusetts and North Dakota. The company has four FDA-approved DMD therapies, including Elevidys, the first approved gene therapy for the disorder, and maintains a pipeline targeting neuromuscular diseases.

At a glance

Attribute

Detail

Founded

1980

Headquarters

Cambridge, Massachusetts

Employees

500-1,000

Revenue

$1-5B (estimated)

What Sarepta Therapeutics makes

The company operates a fully integrated platform encompassing drug discovery, development, manufacturing, and commercialization for genetic therapies and is advancing RNA-based treatments for conditions including myotonic dystrophy type 1.

Latest developments

Facilities

Sarepta Therapeutics is headquartered in Cambridge, Massachusetts. Public sources also reference these locations:

Company details

Sarepta maintains a global presence with offices across Europe and Brazil and serves patients through disease-specific clinical trial programs and patient advocacy initiatives. Sarepta Therapeutics was founded in 1980, has an estimated 500-1,000 employees, and is headquartered in Cambridge, Massachusetts.

Frequently asked questions

What does Sarepta Therapeutics do?

Sarepta Therapeutics is a biopharmaceutical company founded in 1980 and headquartered in Cambridge, Massachusetts, with 500 to 1,000 employees and estimated revenue of $1 billion to $5 billion. It develops precision genetic medicines for rare genetic diseases, particularly Duchenne muscular dystrophy, and operates facilities in Massachusetts and North Dakota. The company has four FDA-approved DMD therapies, including Elevidys, the first approved gene therapy for the disorder, and maintains a pipeline targeting neuromuscular diseases.

Where is Sarepta Therapeutics headquartered?

Sarepta Therapeutics is headquartered in Cambridge, Massachusetts (215 First Street, Cambridge, Massachusetts, 02142).

When was Sarepta Therapeutics founded?

Sarepta Therapeutics was founded in 1980.

How big is Sarepta Therapeutics?

Sarepta Therapeutics has an estimated 500-1,000 employees, with revenue in the $1-5B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Cambridge, Massachusetts (HQ)Headquarters · United States
Cambridge, Massachusetts (HQ)215 First Street, Cambridge, Massachusetts, 02142, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.